Browse Drug Recalls
14,380 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 14,380 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 14,380 FDA drug recalls, Class II.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Nov 1, 2019 | Ranitidine Syrup (Ranitidine Oral Solution USP), 15 mg/mL, 150 mg/10 mL per c... | CGMP Deviations: Presence of NDMA impurity detected in product. | Class II | American Health Packaging |
| Nov 1, 2019 | Hydrocodone Bitartrate and Homatropine Methlybromide Oral Solution 5 mg/1.5 m... | Presence of Foreign Substance: Black particles were found in the lots during retain sample inspec... | Class II | KVK-Tech, Inc. |
| Oct 31, 2019 | LETS GEL KIT Convenience Pack (To prepare 100 mL LETS GEL), Contains: LETS Po... | Microbial contamination of non-sterile product. | Class II | Fagron, Inc |
| Oct 30, 2019 | Potassium Phosphate, Monobasic, Crystal, NF, Multi-Compendial, Bulk Pharmaceu... | Failed Stability Specifications: Product exceeds compendia and firm's specifications for iron con... | Class II | Avantor Performance Materials Inc |
| Oct 28, 2019 | Lannett Ranitidine Syrup (Ranitidine Oral Solution, USP), 15mg/mL Rx Only Di... | CGMP Deviations: Presence of NDMA impurity detected in product. | Class II | Lannett Company, Inc. |
| Oct 25, 2019 | Novitium Pharma Ranitidine Capsules 300 mg 100 capsules Rx Only Manufactured ... | CGMP Deviations: Presence of NDMA impurity detected in product. | Class II | Novitium Pharma LLC |
| Oct 25, 2019 | Novitium Pharma Ranitidine Capsules 150 mg 500 capsules Rx Only Manufactured ... | CGMP Deviations: Presence of NDMA impurity detected in product. | Class II | Novitium Pharma LLC |
| Oct 25, 2019 | Novitium Pharma Ranitidine Capsules 150 mg 60 capsules Rx Only Manufactured b... | CGMP Deviations: Presence of NDMA impurity detected in product. | Class II | Novitium Pharma LLC |
| Oct 25, 2019 | Novitium Pharma Ranitidine Capsules 300 mg 30 capsules Rx Only Manufactured b... | CGMP Deviations: Presence of NDMA impurity detected in product. | Class II | Novitium Pharma LLC |
| Oct 23, 2019 | Regular Strength Acid Reducer, Ranitidine tablets, USP 75 mg, 80 tablets per ... | CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine. | Class II | Perrigo Company PLC |
| Oct 23, 2019 | Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 50 tablets per... | CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine. | Class II | Perrigo Company PLC |
| Oct 23, 2019 | Regular Strength Acid Reducer, Ranitidine tablets, USP 75 mg, 30 tablets per ... | CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine. | Class II | Perrigo Company PLC |
| Oct 23, 2019 | Maximum Strength Acid Reducer, Cool Mint Ranitidine tablets, USP 150 mg, 95 t... | CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine. | Class II | Perrigo Company PLC |
| Oct 23, 2019 | Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 24 tablets per... | CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine. | Class II | Perrigo Company PLC |
| Oct 23, 2019 | Regular Strength Acid Reducer, Ranitidine tablets, USP 75 mg, 160 tablets per... | CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine. | Class II | Perrigo Company PLC |
| Oct 23, 2019 | Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 90 tablets per... | CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine. | Class II | Perrigo Company PLC |
| Oct 23, 2019 | Maximum Strength Acid Reducer, Cool Mint Ranitidine tablets, USP 150 mg, 40 t... | CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine. | Class II | Perrigo Company PLC |
| Oct 23, 2019 | Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 200 tablets pe... | CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine. | Class II | Perrigo Company PLC |
| Oct 23, 2019 | Maximum Strength Acid Reducer, Cool Mint Ranitidine tablets, USP 150 mg, 24 t... | CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine. | Class II | Perrigo Company PLC |
| Oct 23, 2019 | Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 65 tablets per... | CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine. | Class II | Perrigo Company PLC |
| Oct 23, 2019 | Maximum Strength Acid Reducer, Cool Mint Ranitidine tablets, USP 150 mg, 65 t... | CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine. | Class II | Perrigo Company PLC |
| Oct 23, 2019 | Regular Strength Acid Reducer, Ranitidine tablets, USP 75 mg, 150 tablets per... | CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine. | Class II | Perrigo Company PLC |
| Oct 23, 2019 | Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 95 tablets per... | CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine. | Class II | Perrigo Company PLC |
| Oct 23, 2019 | Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 8 tablets. [ND... | CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine. | Class II | Perrigo Company PLC |
| Oct 23, 2019 | Alprazolam Tablets, USP 0.5 mg, 500-count bottles, Rx only, Manufactured for:... | Presence of Foreign Substance | Class II | Mylan Pharmaceuticals Inc. |
| Oct 23, 2019 | Maximum Strength Acid Reducer, Cool Mint Ranitidine tablets, USP 150 mg, 90 t... | CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine. | Class II | Perrigo Company PLC |
| Oct 23, 2019 | Regular Strength Acid Reducer, Ranitidine tablets, USP 75 mg, 60 tablets per ... | CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine. | Class II | Perrigo Company PLC |
| Oct 22, 2019 | Regular Strength Zantac 150 mg, Distributed by: Chattem, Inc., a Sanofi Compa... | CGMP Deviations: Presence of NDMA impurity detected in product. | Class II | Sanofi-Aventis U.S. LLC |
| Oct 22, 2019 | Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, ... | CGMP Deviations: Presence of NDMA impurity detected in product. | Class II | Sanofi-Aventis U.S. LLC |
| Oct 22, 2019 | Regular Strength Zantac 150 mg Distributed by: Chattem, Inc., a Sanofi Compan... | CGMP Deviations: Presence of NDMA impurity detected in product. | Class II | Sanofi-Aventis U.S. LLC |
| Oct 22, 2019 | Cool Mint Tablets Maximum Strength Zantac 150 mg Sanofi Distributed by: Chatt... | CGMP Deviations: Presence of NDMA impurity detected in product. | Class II | Sanofi-Aventis U.S. LLC |
| Oct 22, 2019 | Regular Strength Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Compan... | CGMP Deviations: Presence of NDMA impurity detected in product. | Class II | Sanofi-Aventis U.S. LLC |
| Oct 22, 2019 | Regular Strength Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Compan... | CGMP Deviations: Presence of NDMA impurity detected in product. | Class II | Sanofi-Aventis U.S. LLC |
| Oct 22, 2019 | Zantac 150 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219,... | CGMP Deviations: Presence of NDMA impurity detected in product. | Class II | Sanofi-Aventis U.S. LLC |
| Oct 22, 2019 | Estradiol Vaginal Inserts USP, 10 mcg, packaged in a) 8-count Vaginal Inserts... | Defective Delivery System: complaints for difficulty in pushing the plunger of the applicator. | Class II | Glenmark Pharmaceuticals Inc., USA |
| Oct 22, 2019 | Regular Strength Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Compan... | CGMP Deviations: Presence of NDMA impurity detected in product. | Class II | Sanofi-Aventis U.S. LLC |
| Oct 22, 2019 | Maximum Strength Zantac 150 mg Distributed by: Chattem, Inc., a Sanofi Compan... | CGMP Deviations: Presence of NDMA impurity detected in product. | Class II | Sanofi-Aventis U.S. LLC |
| Oct 22, 2019 | Maximum Strength Zantac 150 mg, Distributed by: Chattem, Inc., a Sanofi Compa... | CGMP Deviations: Presence of NDMA impurity detected in product. | Class II | Sanofi-Aventis U.S. LLC |
| Oct 22, 2019 | Cool Mint Maximum Strength Zantac 150 mg, Distributed by: Chattem, Inc., a Sa... | CGMP Deviations: Presence of NDMA impurity detected in product. | Class II | Sanofi-Aventis U.S. LLC |
| Oct 22, 2019 | Regular Strength Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Compan... | CGMP Deviations: Presence of NDMA impurity detected in product. | Class II | Sanofi-Aventis U.S. LLC |
| Oct 18, 2019 | Miracle Facelift Masque, All Natural, The Miracle in a Bottle, 2 fl. oz./60 m... | Marketed without an Approved NDA/ANDA | Class II | Basic Reset Inc. |
| Oct 18, 2019 | Basic Reset CBD Reset 750 True Full Spectrum Cinnamon, 750 mg CBD, 1 fl. oz. ... | Marketed without an Approved NDA/ANDA | Class II | Basic Reset Inc. |
| Oct 18, 2019 | Basic Reset Nuovi Skin Toner, Refined Ionyte, 4 FL. OZ., 118.3 mL bottle, Dis... | Marketed without an Approved NDA/ANDA | Class II | Basic Reset Inc. |
| Oct 18, 2019 | Basic Reset Earth Wash Cleaner and Personal Care, Eco Friendly, Non Toxic, 2 ... | Marketed without an Approved NDA/ANDA | Class II | Basic Reset Inc. |
| Oct 18, 2019 | Prasugrel Tablets 5 mg, 30-count bottles, Rx only, Manufactured for: Mylan Ph... | Failed Dissolution Specification: Low out of specification dissolution results. | Class II | Mylan Pharmaceuticals Inc. |
| Oct 18, 2019 | Basic Reset CBD Reset 750 True Full Spectrum Natural Flavor 750 mg CBD 1 fl. ... | Marketed without an Approved NDA/ANDA | Class II | Basic Reset Inc. |
| Oct 18, 2019 | Basic Reset CBD Reset 750 True Full Spectrum Wintergreen, 750 mg CBD, 1 fl. o... | Marketed without an Approved NDA/ANDA | Class II | Basic Reset Inc. |
| Oct 18, 2019 | BIOGENYX True Full Spectrum CBD Oil Natural Flavor, 1 fl. oz. (30 mL) bottle,... | Marketed without an Approved NDA/ANDA | Class II | Basic Reset Inc. |
| Oct 18, 2019 | Nuovi Firming Masque, Renew and Reset, 2 fl. oz. 59 mL bottle, Made in USA ex... | Marketed without an Approved NDA/ANDA | Class II | Basic Reset Inc. |
| Oct 18, 2019 | BIOGENYX True Full Spectrum CBD Oil Wintergreen, 1 fl. oz. (30 mL) bottle, 75... | Marketed without an Approved NDA/ANDA | Class II | Basic Reset Inc. |
Frequently Asked Questions
When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.